Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
28.51
-0.92 (-3.13%)
At close: Sep 28, 2026, 4:00 PM EDT
29.14
+0.63 (2.21%)
Pre-market: Sep 29, 2026, 8:46 AM EDT

Adaptive Biotechnologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
308.08276.98178.96170.28185.31154.34
Revenue Growth
50.13%54.77%5.10%-8.11%20.06%56.88%
Gross Profit
144.62111.853.92-27.39-14.36-37.3
Operating Income
-37.46-57.12-155.34-201.61-200.19-208.97
Net Income
-63.85-59.5-159.49-225.25-200.19-207.28
Earnings Per Share
-0.41-0.39-1.08-1.56-1.40-1.48
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Minimal Residual Disease (MRD)
251.94212.33145.53102.7487.14
Immune Medicine
56.1564.6433.4367.5498.16
Total
308.08276.98178.96170.28185.31

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
371.74240.21255.95346.4498.2570.21
Total Debt
410.5210.36222.67229.43233.36111.74
Net Cash (Debt)
-38.7629.8633.29116.97264.83458.47
Net Cash Growth
--10.30%-71.54%-55.83%-42.23%-34.41%
Net Cash Per Share
-0.250.200.230.811.863.27

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-21.01-45.99-95.21-156.32-183.95-192.73
Capital Expenditures
-3.03-2.96-3.66-10.7-16.35-61.75
Free Cash Flow
-24.03-48.95-98.88-167.02-200.29-254.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.94%40.38%2.19%-16.09%-7.75%-24.17%
Operating Margin
-12.16%-20.62%-86.80%-118.40%-108.03%-135.39%
Pretax Margin
-20.77%-21.47%-89.18%-132.32%-108.13%-134.31%
Profit Margin
-20.73%-21.48%-89.12%-132.28%-108.03%-134.30%
FCF Margin
-7.80%-17.67%-55.25%-98.09%-108.09%-164.87%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.778.954.944.175.9025.66